![Glynn Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 801 699 $ in data 31/07/2026
Dr. Glynn Wilson is a Chief Executive Officer & Director at Caring Brands, Inc. and an Independent Director at Cadrenal Therapeutics, Inc. He is on the Board of Directors at Caring Brands, Inc. and Cadrenal Therapeutics, Inc. Dr. Wilson was previously employed as a Chief Scientific Officer by Bonk, Inc., a Chief Scientific Officer by Auriga Laboratories, Inc. /Old/, a Chairman by TapImmune, Inc., a Chairman by Tapimmune, Inc., a President & Chief Executive Officer by PharmaSpec Corp., a Vice President-Research & Development by PlasmaTech Biopharmaceuticals, Inc., a Chief Scientific Officer by Tacora Corp, a Head-Worldwide Drug Delivery by Smithkline Beecham Plc, a Research Head-Cell & Molecular Biology by Ciba-Geigy Pharmaceuticals, and a President & Chief Executive Officer by The GW Group.
He received his doctorate degree from The Rockefeller University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
5,5% | 04/05/2026 | 500.000 ( 5,5% ) | 795 000 $ | 31/07/2026 |
| 27/07/2026 | 3.333 ( 0,11% ) | 6 699 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/01/2023 |
| Società | Posizione | Fine |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Amministratore Delegato | 25/09/2017 |
Tapimmune, Inc. | Amministratore Delegato | 01/09/2017 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Presidente | 13/03/2006 |
PharmaSpec Corp. | Presidente | 01/01/2000 |
| ABEONA THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/01/1998 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Tacora Corp
 Tacora Corp Miscellaneous Commercial ServicesCommercial Services Develops bioresponsive smart polymers | Commercial Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW Group | |
PharmaSpec Corp. | |
Ciba-Geigy Pharmaceuticals | |
Safety Shot, Inc.
 Safety Shot, Inc. Pharmaceuticals: OtherHealth Technology Manufactures photocil dietary supplement products | Health Technology |
Tapimmune, Inc. | |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
